Bengaluru-based biotechnology startup CrisprBits Private Limited has raised USD 3 Million through founders, angels & family ...

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.

The market offers strong growth potential driven by advancements in genetic engineering for efficient pharmaceutical protein ...

Former Horizon Discovery CEO Terry Pizzie has been appointed to a similar role with Cambridge based Broken String Biosciences ...

After releasing two gene-edited rice varieties in May this year, scientists are now focusing on developing GE varieties of ...

Sustainable bioprocessing boosts cyanobacterial pigment production for advanced biomedical, imaging, and commercial applications.

Intellia Therapeutics NTLA has made good progress with the advancement of its in vivo candidate, lonvo-z (or, NTLA-2002), which is currently in late-stage development for hereditary angioedema (HAE).

Intellia Therapeutics, Inc. (NASDAQ:NTLA) ranks among the most oversold biotech stocks to invest in. On November 11, Jones Trading dropped Intellia Therapeutics, Inc. (NASDAQ:NTLA) from Buy to Hold.

Mirkin is one of only two Northwestern University faculty members to receive this prestigious award. He joins professor and IIN-affiliated faculty member Tobin J. Marks, who received the 2017 Harvey ...

Here are Cathie Wood’s latest moves.

Background Diffuse gastric cancer (DGC) is the most common manifestation in germline CTNNA1 variant carriers, with one study estimating a 49–57% lifetime risk by age 80. Knowledge on CTNNA1-associated ...

Sharpen your Mains answer-writing skills with GS-3 questions by following the thought process. Do not miss points to ponder ...